ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for deadly thyroid cancer? drug combo tested before surgery
Disease control Recruiting nowThis early-phase trial is testing whether giving a combination of two drugs (XL092 and cemiplimab) before surgery can help people with a rare and fast-growing thyroid cancer called anaplastic thyroid cancer. The study will enroll 12 participants to see if the treatment is safe an…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo targets deadly thyroid cancer in small trial
Disease control Recruiting nowThis phase 2 trial is testing whether two drugs, pembrolizumab and lenvatinib, can shrink tumors and improve survival in 20 people with anaplastic thyroid cancer, a rare and fast-growing cancer. Participants will receive both drugs and be monitored for response and side effects. …
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
New study tracks thyroid cancer patients outside clinical trials
Knowledge-focused Recruiting nowThis study observes adults with advanced thyroid cancer who are receiving standard treatments in real-world settings, not in clinical trials. Researchers aim to understand barriers to accessing care and how well patients tolerate and respond to available medications. About 459 pa…
Matched conditions: ANAPLASTIC THYROID CANCER
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC